Ancient herb mix takes on brain bleed: can it stop repeat strokes?
NCT ID NCT07250035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a traditional Chinese medicine called Jiedu Huayu oral prescription in 436 people who have had a brain bleed due to a condition called cerebral amyloid angiopathy. The goal is to see if the herbal treatment can lower the chance of having another stroke or blood vessel event. Participants will receive either the herbal medicine or a placebo for up to a year, and researchers will track any new vascular events and changes in thinking abilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Jiedu Huayu oral prescription (a traditional Chinese medicine compound)
What this could lead to
If it works, this could provide a new treatment option to reduce the risk of further strokes or bleeding in people with cerebral amyloid angiopathy.
What could go wrong
This is an early Phase 3 trial, and the treatment is a traditional Chinese medicine with limited prior evidence. It may not prove effective, and there is a risk of allergic reactions to its components.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL AMYLOID ANGIOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University
RECRUITINGBeijing, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••